Nano Dentica, global commercialisation of bioactive fluorapatite
| Reference number | |
| Coordinator | Nano Dentica AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | September 2024 - April 2025 |
| Status | Ongoing |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Competence Enhancement in Small Businesses 2024 |
Purpose and goal
The project will be divided into two important issues. Set a strategic plan for regulatory approval of an FA-based product as well as develop a plan for the commercialization of FA as a surface application.
Expected effects and result
Our results are expected to be seen in a clear plan for a regulatory process of an FA-based product. This plan will be well structured and defined according to the requirements of various regulatory authorities. A commercialization plan must also be well worked out with regard to potential customers and various markets. In the end, Nano Dentica will have two clear strategies for two important issues.
Planned approach and implementation
We will create them two important plans in parallel. Various questions concerning the regulatory requirements such as the ISO standard in production, documentation and safety for patients and possible registration of substances will be answered and mapped. Also, for the second plan covering commercialization, issues including any eligibility requirements in various applications (orthopaedics vs dentistry, for example), IP, and quality, among others will be prioritized.